FI956057A - Intracellulära bindningsproteiner (PIL) och deras användning - Google Patents
Intracellulära bindningsproteiner (PIL) och deras användning Download PDFInfo
- Publication number
- FI956057A FI956057A FI956057A FI956057A FI956057A FI 956057 A FI956057 A FI 956057A FI 956057 A FI956057 A FI 956057A FI 956057 A FI956057 A FI 956057A FI 956057 A FI956057 A FI 956057A
- Authority
- FI
- Finland
- Prior art keywords
- pct
- binding proteins
- date dec
- pil
- intracellular binding
- Prior art date
Links
- 230000003834 intracellular effect Effects 0.000 title abstract 3
- 102000014914 Carrier Proteins Human genes 0.000 title abstract 2
- 108091008324 binding proteins Proteins 0.000 title abstract 2
- 150000007523 nucleic acids Chemical group 0.000 abstract 2
- 108700042226 ras Genes Proteins 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000004962 mammalian cell Anatomy 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/084—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1072—Regulatory proteins, e.g. tat, rev, vpt
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9307241A FR2706486B1 (fr) | 1993-06-16 | 1993-06-16 | Séquences nucléiques, vecteurs les contenant, compositions pharmaceutiques et utilisations thérapeutiques. |
| FR9307241 | 1993-06-16 | ||
| PCT/FR1994/000714 WO1994029446A2 (fr) | 1993-06-16 | 1994-06-15 | Proteines intracellulaires de liaison (pil) et leurs utilisations |
| FR9400714 | 1994-06-15 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI956057A true FI956057A (sv) | 1995-12-15 |
| FI956057A0 FI956057A0 (sv) | 1995-12-15 |
| FI120311B FI120311B (sv) | 2009-09-15 |
Family
ID=9448183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI956057A FI120311B (sv) | 1993-06-16 | 1995-12-15 | Förfaranden för framställning av nukleinsyror, som kodar för intracellulära bindningproteiner (PIL), och virus, vektorer och farmaceutiska kompositioner, som innehåller dessa |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6159947A (sv) |
| EP (1) | EP0703980B1 (sv) |
| JP (1) | JP4384260B2 (sv) |
| KR (1) | KR100342233B1 (sv) |
| CN (1) | CN1076052C (sv) |
| AT (1) | ATE231916T1 (sv) |
| AU (1) | AU7076394A (sv) |
| BR (1) | BR9407512A (sv) |
| CA (1) | CA2165458C (sv) |
| CZ (1) | CZ289039B6 (sv) |
| DE (1) | DE69432075T2 (sv) |
| DK (1) | DK0703980T3 (sv) |
| ES (1) | ES2191031T3 (sv) |
| FI (1) | FI120311B (sv) |
| FR (1) | FR2706486B1 (sv) |
| HU (1) | HU219138B (sv) |
| NO (1) | NO319466B1 (sv) |
| NZ (1) | NZ268038A (sv) |
| PL (1) | PL180760B1 (sv) |
| RU (1) | RU2218400C2 (sv) |
| SK (1) | SK285169B6 (sv) |
| UA (1) | UA46709C2 (sv) |
| WO (1) | WO1994029446A2 (sv) |
| ZA (1) | ZA944303B (sv) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8003342B1 (en) | 1990-04-18 | 2011-08-23 | Board Of Regents, The University Of Texas System | Method for identifying farnesyl transferase inhibitors |
| US6790633B1 (en) * | 1990-04-18 | 2004-09-14 | Michael S. Brown | Method of inhibiting a farnesyl transferase enzyme |
| FR2724320B1 (fr) * | 1994-09-13 | 1996-12-20 | Transgene Sa | Nouvel implant pour le traitement des maladies acquises |
| US5518042A (en) * | 1994-09-16 | 1996-05-21 | Huyck Licensco, Inc. | Papermaker's forming fabric with additional cross machine direction locator and fiber supporting yarns |
| FR2738151B1 (fr) * | 1995-09-04 | 1997-09-26 | Rhone Poulenc Rorer Sa | Antagonistes de l'activite oncogenique de la proteine mdm2, et leur utilisation dans le traitement des cancers |
| CN100497610C (zh) | 1996-12-06 | 2009-06-10 | 阿温蒂斯药物公司 | 人脂酶样基因编码的多肽及利用它的组合物和方法 |
| US7008776B1 (en) * | 1996-12-06 | 2006-03-07 | Aventis Pharmaceuticals Inc. | Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol |
| FR2758569B1 (fr) * | 1997-01-20 | 1999-04-02 | Centre Nat Rech Scient | Materiel biologique pour le traitement d'un mammifere par transfert de gene d'anticorps et composition pharmaceutique le concernant |
| AU3604800A (en) * | 1999-02-26 | 2000-09-14 | Mindset Biopharmaceuticals (Usa) Ltd. | Method for regulating the stability of recombinant proteins, and antibodies and products useful therein |
| FR2794771B1 (fr) | 1999-06-11 | 2001-08-10 | Aventis Pharma Sa | Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis) |
| GB0018307D0 (en) | 2000-07-26 | 2000-09-13 | Aventis Pharm Prod Inc | Polypeptides |
| MXPA02009481A (es) | 2000-03-31 | 2004-05-14 | Aventis Pharma Inc | Factor inductor del factor nuclear kb. |
| AU2002338446A1 (en) * | 2001-01-23 | 2002-11-05 | University Of Rochester Medical Center | Methods of producing or identifying intrabodies in eukaryotic cells |
| WO2012162628A2 (en) | 2011-05-25 | 2012-11-29 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Lipopeptide inhibitors of ras oncoproteins |
| KR101602870B1 (ko) | 2014-07-22 | 2016-03-21 | 아주대학교산학협력단 | 완전한 이뮤노글로불린 형태의 항체를 세포막을 투과하여 세포질에 위치시키는 방법 및 그의 이용 |
| KR101602876B1 (ko) | 2014-07-22 | 2016-03-11 | 아주대학교산학협력단 | 완전한 이뮤노글로불린 형태의 세포질 침투능을 갖는 항체를 이용하여 세포내 활성화된 ras를 억제하는 방법 및 그의 이용 |
| US20180072815A1 (en) | 2014-10-23 | 2018-03-15 | Singh Biotechnology, Llc | Single Domain Antibodies Directed Against Intracellular Antigens |
| DK3209685T3 (da) * | 2014-10-23 | 2019-07-29 | Singh Molecular Medicine Llc | Enkeltdomæneantistoffer rettet mod intracellulære antigener |
| TWI746473B (zh) | 2015-11-02 | 2021-11-21 | 美商辛分子醫藥有限公司 | 針對細胞內抗原之單域抗體 |
| JP2019520086A (ja) | 2016-05-27 | 2019-07-18 | オラム・セラピューティクス・インコーポレイテッド | 細胞質浸透抗体およびその用途 |
| KR20190143826A (ko) | 2018-06-21 | 2019-12-31 | 오름테라퓨틱 주식회사 | 세포/조직 특이적 세포 침투 항체 |
| CN110981943B (zh) * | 2019-12-02 | 2021-08-03 | 清华大学 | 多肽及其在制备药物中的用途和药物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946778A (en) * | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| DE3915952A1 (de) * | 1989-05-12 | 1990-12-06 | Peter Werner | Wirkstoff/medikament/biotechnologisches verfahren zur behandlung von erkrankungen, die mit exo- oder endogenen intrazellulaeren proteinen (onkogene etc.) assoziert sind |
| CA2092319A1 (en) * | 1990-09-25 | 1992-03-26 | George Y. Wu | Prolonging expression of polynucleotides introduced into a cell |
| CA2072249C (en) * | 1991-06-28 | 2003-06-17 | Saiko Hosokawa | Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane |
| AU675413B2 (en) * | 1991-09-30 | 1997-02-06 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | Recombinant immunotoxins |
| CA2125396A1 (en) * | 1991-12-10 | 1993-06-24 | Wayne A. Marasco | Reactive neutralizing human anti-gp 120 recombinant antibody, dna coding the same and use thereof |
| DE69334095T2 (de) * | 1992-07-17 | 2007-04-12 | Dana-Farber Cancer Institute, Boston | Verfahren zur intrazellulären Bindung von zielgerichteten Molekülen |
-
1993
- 1993-06-16 FR FR9307241A patent/FR2706486B1/fr not_active Expired - Lifetime
-
1994
- 1994-06-15 HU HU9503615A patent/HU219138B/hu not_active IP Right Cessation
- 1994-06-15 NZ NZ268038A patent/NZ268038A/en not_active IP Right Cessation
- 1994-06-15 KR KR1019950705716A patent/KR100342233B1/ko not_active IP Right Cessation
- 1994-06-15 BR BR9407512A patent/BR9407512A/pt not_active Application Discontinuation
- 1994-06-15 SK SK1568-95A patent/SK285169B6/sk not_active IP Right Cessation
- 1994-06-15 AU AU70763/94A patent/AU7076394A/en not_active Abandoned
- 1994-06-15 CZ CZ19953295A patent/CZ289039B6/cs not_active IP Right Cessation
- 1994-06-15 AT AT94919711T patent/ATE231916T1/de active
- 1994-06-15 PL PL94312213A patent/PL180760B1/pl not_active IP Right Cessation
- 1994-06-15 RU RU96100240/13A patent/RU2218400C2/ru not_active IP Right Cessation
- 1994-06-15 EP EP94919711A patent/EP0703980B1/fr not_active Expired - Lifetime
- 1994-06-15 DK DK94919711T patent/DK0703980T3/da active
- 1994-06-15 CA CA2165458A patent/CA2165458C/fr not_active Expired - Fee Related
- 1994-06-15 JP JP50143495A patent/JP4384260B2/ja active Active
- 1994-06-15 CN CN94192443A patent/CN1076052C/zh not_active Expired - Fee Related
- 1994-06-15 DE DE69432075T patent/DE69432075T2/de not_active Expired - Lifetime
- 1994-06-15 UA UA95125274A patent/UA46709C2/uk unknown
- 1994-06-15 US US08/564,164 patent/US6159947A/en not_active Expired - Lifetime
- 1994-06-15 WO PCT/FR1994/000714 patent/WO1994029446A2/fr active IP Right Grant
- 1994-06-15 ES ES94919711T patent/ES2191031T3/es not_active Expired - Lifetime
- 1994-06-16 ZA ZA944303A patent/ZA944303B/xx unknown
-
1995
- 1995-12-11 NO NO19955011A patent/NO319466B1/no not_active IP Right Cessation
- 1995-12-15 FI FI956057A patent/FI120311B/sv not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI956057A (sv) | Intracellulära bindningsproteiner (PIL) och deras användning | |
| ATE400651T1 (de) | Verwendung von grünem fluoreszenzprotein | |
| ATE348175T1 (de) | Method eder intrazellularen bindung von zielgerichteten molekülen | |
| FI934811A0 (fi) | Stabiliserade enzymer och detergentfoereningar | |
| WO1996039429A3 (en) | Serum protein produced exclusively in adipocytes | |
| GR3025982T3 (en) | Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody. | |
| IT1261847B (it) | Metodo per marcare cellule eucariote. | |
| ATE373708T1 (de) | Ein homeobox-faktor der insulin-expression in pankreatischen inselnzellen stimuliert | |
| TW272197B (sv) | ||
| DE69637154D1 (de) | Hocheffizientes gewebespezifisches system zur bereitstellung von verbindungen unter verwendung eines streptavidin-protein a fusionsproteins | |
| FI942442A0 (sv) | Produktion av proteiner genom användning av 7B2-protein | |
| FI961202A (sv) | Grb3-3-gen, dess varianter och deras användningar | |
| ES2161245T3 (es) | Gen marcador. | |
| ATE417112T1 (de) | Steigerung der immunantwort unter verwendung von zielgerichteten molekülen | |
| ATE274351T1 (de) | Verwendung von isolierten domänen des type-iv- kollagens zur änderung der zell- und gewebewechselwirkung | |
| DK0773999T3 (da) | OR-1, en orphan-receptor tilhørende kernereceptorfamilien | |
| IT1275909B1 (it) | Frammento di dna codificante d-amminoacido ossidasi | |
| DK0788549T3 (da) | Regulerende nukleinsyresekvenser og anvendelser | |
| DE69739263D1 (de) | Produktion von proteinen, dafür kodierende plasmide und organismen, die solche plasmide enthalten | |
| DE59611353D1 (de) | Transketolase-verwandtes protein | |
| MX9709459A (es) | Metodo para prolongar la expresion de un gen de interes usando moleculas de ctla4 solubles. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Transfer of assignment of patent |
Owner name: AVENTIS PHARMA S.A. |
|
| FG | Patent granted |
Ref document number: 120311 Country of ref document: FI |
|
| MM | Patent lapsed |